Spleen and Stomach Diseases

【Department Establishment History】 The Department of Spleen and Stomach Diseases was established in 2005. 【Department Honors】 It is currently a Key Specialty of the National Administration of Traditional Chinese Medicine, a National Specialty of Traditional Chinese Medicine Excellence, and a High-Level Key Specialty of Guangdong Province. It is a nationally renowned diagnosis and treatment center for spleen and stomach diseases, integrating medical care, teaching, scientific research, prevention, and rehabilitation. 【Department Leadership】 Professor Huang Minghe, Professor Li Jian, and Professor Guo Shaoju successively served as administrative directors of the department, making outstanding contributions to its development. 【Research Areas】 The department is committed to integrated Chinese and Western medicine diagnosis, treatment, scientific research, and teaching in areas including early gastrointestinal cancer and precancerous lesions, biliary and pancreatic diseases, functional gastrointestinal disorders, and inflammatory bowel disease. It has established an integrated diagnosis and treatment system of “precision diagnosis—minimally invasive treatment—whole-course intervention with traditional Chinese medicine.” 【Department Services and Activities】 The department has 2 National Master Traditional Chinese Medicine Inheritance Studios, 2 renowned traditional Chinese medicine physicians of Guangdong Province, 3 renowned traditional Chinese medicine physicians of Shenzhen, 2 doctoral supervisors, 11 master's supervisors, and more than 100 staff members. It has established 7 subspecialty diagnosis and treatment teams, with 128 modern inpatient beds and 20 full-process digestive endoscopy examination rooms. It is equipped with internationally leading endoscopic devices, including ultra-high-definition gastroscopes and colonoscopes, endoscopic ultrasonography, enteroscopes, and SpyGlass. It handles more than 140,000 outpatient visits, more than 5,000 discharges, and more than 50,000 endoscopic procedures annually. With support from Shenzhen's “Three Famous” Project for Medical and Health Services, it has introduced the Spleen and Stomach Disease Research Team led by Professor Tang Xudong of Xiyuan Hospital, a Chief Researcher at the China Academy of Chinese Medical Sciences and a Qihuang Scholar. Through resource sharing and collaborative innovation, this has injected strong momentum into the department's high-quality development. The department fully leverages the complementary strengths of Chinese and Western medicine: in early gastrointestinal cancer and precancerous lesions, it relies on detailed examination with high-definition endoscopy and minimally invasive endoscopic ESD treatment, combined with hospital-prepared formulations such as Weiwèi Granules and Jianpi Hewei Formula, to rapidly relieve discomfort such as epigastric pain and epigastric fullness, and effectively treat precancerous lesions such as atrophy and intestinal metaplasia; in biliary and pancreatic diseases, it performs gallbladder-preserving stone extraction and ERCP, combined with appropriate traditional Chinese medicine techniques such as acupuncture and the Tuina Meridian Circulation Device, to reduce the risk of stone recurrence; in functional gastrointestinal disorders, it develops individualized Chinese herbal compound formulas, and combines the hospital-prepared formulations “Hewei Jiangni Formula” and “Modified Tong Xie Yao Formula” with acupuncture, moxibustion, thread embedding, plaster application, auricular points, and other multidimensional approaches to regulate gastrointestinal function safely and effectively; in inflammatory bowel disease, it uses double-balloon enteroscopy, capsule endoscopy, biologic agents, and small-molecule drugs to customize individualized fecal microbiota transplantation plans, and combines the hospital-prepared Shen Dai Yu Yang Enema Solution and Li Chang Formula with moxibustion and plaster application, achieving complementary advantages of Chinese and Western medicine. The department follows a strategy of coordinated development of clinical practice, scientific research, and teaching; it has established a high-level talent training platform; trained nearly 20 doctoral and postdoctoral fellows; initiated 17 National Natural Science Foundation of China projects and nearly 40 provincial- and municipal-level research projects; conducted 11 horizontal collaborative projects with Xiyuan Hospital of the China Academy of Chinese Medical Sciences, Guangzhou University of Chinese Medicine, and other institutions; received authorization for more than 20 patents in total; published 6 academic monographs; and published more than 100 academic papers. In the future, the department will build on its past achievements and continue to explore, injecting new vitality into patients' health and the development of diagnosis and treatment for spleen and stomach diseases in traditional Chinese medicine. 【Department Group Photo】